GlassScriptAtellica Im 1300 Analyzer
Payments companies reported to CMS as associated with Atellica Im 1300 Analyzer. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Atellica Im 1300 Analyzer, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Atellica Im 1300 Analyzer
These are the largest totals companies reported as associated with Atellica Im 1300 Analyzer. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Zobair Younossi | Falls Church, VA | Surgery | $32,098.91 |
| James Crawford | Gainesville, FL | Anatomic Pathology | $8,982.70 |
| Mohammed Ali | Decatur, GA | Family Medicine | $7,047.39 |
| Jeffrey Rosen | Coral Gables, FL | Internal Medicine | $6,754.66 |
| Jeffrey Unger | Chino, CA | Family Medicine | $6,581.22 |
| Daniel Katselnik | Shavano Park, TX | Endocrinology, Diabetes & Metabolism | $6,455.40 |
| Javier Morales | Greenvale, NY | Internal Medicine | $5,673.70 |
| Lori Daniels | San Diego, CA | Cardiovascular Disease | $611.97 |
| Hoda Hagrass | Little Rock, AR | Clinical Pathology/Laboratory Medicine | $284.00 |
| Alexander Pederson | Belleville, IL | Anatomic Pathology & Clinical Pathology | $232.87 |
Prescribed Atellica Im 1300 Analyzer?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.